Copyright © 2011 Nasser Zangiabadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. G. Pittenger and A. Vinik, “Nerve growth factor and diabetic neuropathy,” Experimental Diabesity Research, vol. 4, no. 4, pp. 271–285, 2003. View at Scopus
2. K. Sugimoto, Y. Murakawa, and A. A. F. Sima, “Diabetic neuropathy—a continuing enigma,” Diabetes/Metabolism Research and Reviews, vol. 16, no. 6, pp. 408–433, 2000. View at Publisher · View at Google Scholar · View at Scopus
3. P. J. Dyck, B. R. Zimmerman, T. H. Vilen et al., “Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy,” The New England Journal of Medicine, vol. 319, no. 9, pp. 542–548, 1988. View at Scopus
4. L. Eckersley, “Role of the Schwann cell in diabetic neuropathy,” International Review of Neurobiology, vol. 50, pp. 293–321, 2002. View at Scopus
5. G. Lauria, R. Lombardi, M. Borgna et al., “Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation,” Journal of the Peripheral Nervous System, vol. 10, no. 2, pp. 202–208, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. G. Lauria, M. Morbin, R. Lombardi et al., “Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies,” Neurology, vol. 61, no. 5, pp. 631–636, 2003. View at Scopus
7. M. I. Periquet, V. Novak, M. P. Collins et al., “Painful sensory neuropathy,” Neurology, vol. 53, no. 8, pp. 1641–1647, 1999. View at Scopus
8. The Diabetes Control and Complications Trial Research G, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993.
9. N. E. Cameron, M. A. Cotter, M. Basso, and T. C. Hohman, “Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats,” Diabetologia, vol. 40, no. 3, pp. 271–281, 1997. View at Publisher · View at Google Scholar · View at Scopus
10. F. A. Gries, “Alternative therapeutic principles in the prevention of microvascular and neuropathic complications,” Diabetes Research and Clinical Practice, vol. 28, pp. S201–S207, 1995. View at Publisher · View at Google Scholar · View at Scopus
11. N. Karachalias, R. Babaei-Jadidi, N. Ahmed, and P. J. Thornalley, “Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats,” Biochemical Society Transactions, vol. 31, no. 6, pp. 1423–1425, 2003. View at Scopus
12. P. Vague, T. C. Coste, M. F. Jannot, J. D. Raccah, and M. Tsimaratos, “C-peptide, Na+,K+-ATPase, and diabetes,” Experimental Diabesity Research, vol. 5, no. 1, pp. 37–50, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. S. Tesfaye, N. Chaturvedi, S. E. M. Eaton et al., “Vascular risk factors and diabetic neuropathy,” The New England Journal of Medicine, vol. 352, no. 4, pp. 341–350, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman, “Oxidative stress in the pathogenesis of diabetic neuropathy,” Endocrine Reviews, vol. 25, no. 4, pp. 612–628, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. R. Babaei-Jadidi, N. Karachalias, N. Ahmed, S. Battah, and P. J. Thornalley, “Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine,” Diabetes, vol. 52, no. 8, pp. 2110–2120, 2003. View at Publisher · View at Google Scholar · View at Scopus
16. S. Thomas's, “Failure of improved glycaemic control to reverse diabetic autonomic neuropathy,” Diabetic Medicine, vol. 3, no. 4, pp. 330–334, 1986.
17. M. Asadi-Shekaari, M. Panahi, S. H. Dabiri, S. K. Zahed, and T. P. Pour, “Neuroprotective effects of aqueous date fruit extract on focal cerebral ischemia in rats,” Pakistan Journal of Medical Sciences, vol. 24, no. 5, pp. 661–665, 2008. View at Scopus
18. C. Gemma, M. H. Mesches, B. Sepesi, K. Choo, D. B. Holmes, and P. C. Bickford, “Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar β-adrenergic function and increases in proinflammatory cytokines,” Journal of Neuroscience, vol. 22, no. 14, pp. 6114–6120, 2002. View at Scopus
19. A. Mansouri, G. Embarek, E. Kokkalou, and P. Kefalas, “Phenolic profile and antioxidant activity of the Algerian ripe date palm fruit (Phoenix dactylifera),” Food Chemistry, vol. 89, no. 3, pp. 411–420, 2005. View at Publisher · View at Google Scholar · View at Scopus
20. W. Al-Shahib and R. J. Marshall, “The fruit of the date palm: its possible use as the best food for the future?” International Journal of Food Sciences and Nutrition, vol. 54, no. 4, pp. 247–259, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. P. K. Vayalil, “Antioxidant and antimutagenic properties of aqueous extract of date fruit (Phoenix dactylifera L. Arecaceae),” Journal of Agricultural and Food Chemistry, vol. 50, no. 3, pp. 610–617, 2002. View at Publisher · View at Google Scholar · View at Scopus
22. A. K. Sallal and A. Ashkenani, “Effect of date extract on growth and spore germination of Bacillus subtilis,” Microbios, vol. 59, no. 240-241, pp. 203–210, 1989. View at Scopus
23. Z. A. Shraideh, K. H. Abu-Elteen, and A. K. J. Sallal, “Ultrastructural effects of date extract on Candida albicans,” Mycopathologia, vol. 142, no. 3, pp. 119–123, 1998. View at Publisher · View at Google Scholar · View at Scopus
24. O. Ishurd and J. F. Kennedy, “The anti-cancer activity of polysaccharide prepared from Libyan dates (Phoenix dactylifera L.),” Carbohydrate Polymers, vol. 59, no. 4, pp. 531–535, 2005. View at Publisher · View at Google Scholar · View at Scopus
25. A. A. Al-Qarawi, H. Abdel-Rahman, B. H. Ali, H. M. Mousa, and S. A. El-Mougy, “The ameliorative effect of dates (Phoenix dactylifera L.) on ethanol-induced gastric ulcer in rats,” Journal of Ethnopharmacology, vol. 98, no. 3, pp. 313–317, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. M. Lipartiti, D. Franceschini, R. Zanoni et al., “Neuroprotective effects of melatonin,” Advances in Experimental Medicine and Biology, vol. 398, pp. 315–321, 1996. View at Scopus
27. M. Panahi, M. Asadi-Shekaari, T. P. Kalantari Pour, and A. Safavi, “Aqueous extract of date fruit protects CA1 neurons againt oxidative injury: an ultastructural study,” Current Topics in Nutraceutical Research, vol. 6, no. 3, pp. 125–130, 2008.
28. S. Usuki, Y. Ito, K. Morikawa et al., “Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats,” Nutrition & Metabolism, vol. 4, article 25, 2007. View at Publisher · View at Google Scholar · View at PubMed
29. J. Jakobsen, “Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats,” Journal of Neurology Neurosurgery & Psychiatry, vol. 42, no. 6, pp. 509–518, 1979. View at Scopus
30. A. K. Sharma and P. K. Thomas, “Peripheral nerve structure and function in experimental diabetes,” Journal of the Neurological Sciences, vol. 23, no. 1, pp. 1–15, 1974. View at Publisher · View at Google Scholar · View at Scopus
31. D. A. Greene, S. Lattimer-Greene, and A. A. F. Sima, “Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism,” Critical Reviews in Neurobiology, vol. 5, no. 2, pp. 143–219, 1989. View at Scopus
32. J. I. Malone, S. Lowitt, J. K. Korthals, A. Salem, and C. Miranda, “The effect of hyperglycemia on nerve conduction and structure is age dependent,” Diabetes, vol. 45, no. 2, pp. 209–215, 1996. View at Scopus
33. M. Shabani, N. Hosseinmardi, M. Haghani, V. Shaibani, and M. Janahmadi, “Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring,” Neuroscience, vol. 172, no. C, pp. 139–152, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
34. L. Hounsom and D. R. Tomlinson, “Does neuropathy develop in animal models?” Clinical Neuroscience, vol. 4, no. 6, pp. 380–389, 1997. View at Scopus
35. M. Dobretsov, D. Romanovsky, and J. R. Stimers, “Early diabetic neuropathy: triggers and mechanisms,” World Journal of Gastroenterology, vol. 13, no. 2, pp. 175–191, 2007. View at Scopus
36. G. Negi, A. Kumar, R. K. Kaundal, A. Gulati, and S. S. Sharma, “Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy,” Neuropharmacology, vol. 58, no. 3, pp. 585–592, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. A. K. Saini, K. H. S. Arun, C. L. Kaul, and S. S. Sharma, “Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine,” Pharmacological Research, vol. 50, no. 6, pp. 593–599, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. S. Kumar, K. H. S. Arun, C. L. Kaul, and S. S. Sharma, “Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy,” Neurological Research, vol. 27, no. 1, pp. 60–66, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. E. Andriambeloson, C. Baillet, P. A. Vitte, G. Garotta, M. Dreano, and N. Callizot, “Interleukin-6 attenuates the development of experimental diabetes-related neuropathy,” Neuropathology, vol. 26, no. 1, pp. 32–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
40. N. Zangiabadi, “The effect of omega-3 fatty acids on nerve conduction velocity (NCV) and F-wave latency in patients with diabetic polyneuropathy,” The American Journal of Pharmacology and Toxicology, vol. 2, no. 1, pp. 1–3, 2007.
41. T. C. Coste, A. Gerbi, P. Vague, J. M. Maixent, G. Pieroni, and D. Raccah, “Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs?” Cellular and Molecular Biology, vol. 50, no. 7, pp. 845–853, 2004. View at Scopus
42. M. A. Cotter and N. E. Cameron, “Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats,” Life Sciences, vol. 73, no. 14, pp. 1813–1824, 2003. View at Publisher · View at Google Scholar · View at Scopus
43. L. J. Coppey, J. S. Gellett, E. P. Davidson, J. A. Dunlap, and M. A. Yorek, “Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatis nerve,” International Journal of Experimental Diabetes Research, vol. 3, no. 1, pp. 21–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
44. A. Kumar, R. K. Kaundal, S. Iyer, and S. S. Sharma, “Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy,” Life Sciences, vol. 80, no. 13, pp. 1236–1244, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
45. M. J. Callaghan, D. J. Ceradini, and G. C. Gurtner, “Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function,” Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1476–1482, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
46. K. Sugimoto and S. Yagihashi, “Peripheral nerve pathology in rats with streptozotocin-induced insulinoma,” Acta Neuropathologica, vol. 91, no. 6, pp. 616–623, 1996. View at Publisher · View at Google Scholar · View at Scopus
47. A. A. F. Sima and K. Sugimoto, “Experimental diabetic neuropathy: an update,” Diabetologia, vol. 42, no. 7, pp. 773–788, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
48. R. Pop-Busui, A. Sima, and M. Stevens, “Diabetic neuropathy and oxidative stress,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 4, pp. 257–273, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. D. M. Niedowicz and D. L. Daleke, “The role of oxidative stress in diabetic complications,” Cell Biochemistry and Biophysics, vol. 43, no. 2, pp. 289–330, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
50. M. A. Yorek, L. J. Coppey, J. S. Gellett, and E. P. Davidson, “Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes,” Experimental Diabesity Research, vol. 5, no. 3, pp. 187–193, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
51. M. C. Gonzalez Deniselle, L. Garay, S. Gonzalez, R. Guennoun, M. Schumacher, and A. F. De Nicola, “Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease,” Experimental Neurology, vol. 195, no. 2, pp. 518–523, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
52. A. Gerbi, J. M. Maixent, J. L. Ansaldi et al., “Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats,” Journal of Nutrition, vol. 129, no. 1, pp. 207–213, 1999. View at Scopus
53. M. A. Yorek, L. J. Coppey, J. S. Gellett et al., “Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function,” American Journal of Physiology—Endocrinology and Metabolism, vol. 283, no. 5, pp. E1067–E1075, 2002. View at Scopus
54. I. Azcoitia, E. Leonelli, V. Magnaghi, S. Veiga, L. M. Garcia-Segura, and R. C. Melcangi, “Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats,” Neurobiology of Aging, vol. 24, no. 6, pp. 853–860, 2003. View at Publisher · View at Google Scholar · View at Scopus
55. E. Grzeda, R. J. Wiśniewska, and K. Wiśniewski, “Effect of an NMDA receptor agonist on T-maze and passive avoidance test in 12-week streptozotocin-induced diabetic rats,” Pharmacological Reports, vol. 59, no. 6, pp. 656–663, 2007. View at Scopus
56. D. A. Greene, M. J. Stevens, I. Obrosova, and E. L. Feldman, “Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy,” European Journal of Pharmacology, vol. 375, no. 1–3, pp. 217–223, 1999. View at Publisher · View at Google Scholar · View at Scopus
57. M. R. S. Ardekania, M. Khanavia, M. Hajimahmoodib, M. Jahangiria, and A. Hadjiakhoondia, “Comparison of antioxidant activity and total phenol,” Iranian Journal of Pharmaceutical Research, vol. 9, no. 2, pp. 141–146, 2010.
58. M. Asadi-Shekari and S. Rajab Alian, “Antioxidative effect of aqueous date fruit extract in pc12 cell line,” Iranian Journal of Pharmaceutical Research, vol. 3, no. 1, p. 72, 2004.
59. B. Poeggeler, R. J. Reiter, D. X. Tan, L. D. Chen, and L. C. Manchester, “Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis,” Journal of Pineal Research, vol. 14, no. 4, pp. 151–168, 1993. View at Scopus
60. K. Cui, X. Luo, K. Xu, and M. R. Ven Murthy, “Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 28, no. 5, pp. 771–799, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. P. Lyden and N. G. Wahlgren, “Mechanisms of action of neuroprotectants in stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 9, no. 6, part 2, pp. 9–14, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. K. I. Maynard, I. A. Ayoub, and C. C. Shen, “Delayed multidose treatment with nicotinamide extends the degree and duration of neuroprotection by reducing infarction and improving behavioral scores up to two weeks following transient focal cerebral ischemia in Wistar rats,” Annals of the New York Academy of Sciences, vol. 939, pp. 416–424, 2001. View at Scopus
63. O. Vajragupta, P. Boonchoong, Y. Sumanont, H. Watanabe, Y. Wongkrajang, and N. Kammasud, “Manganese-based complexes of radical scavengers as neuroprotective agents,” Bioorganic and Medicinal Chemistry, vol. 11, no. 10, pp. 2329–2337, 2003. View at Publisher · View at Google Scholar · View at Scopus